在子宫内生长受限制的早产婴儿中,纵向炎症生物标志物概况
Laura E Lorenger1, Timothy J Boly2, Rachael M Hyland3
1Stead Family Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA; Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Cytokine
|March 26, 2025
概括
在早产婴儿的子宫内生长限制 (IUGR) 会导致持续的炎症状态,由 IL-8 和 MCP-1 的升高表明. 这种炎症,以及免疫细胞的增加,可能会使这些脆弱的新生儿的结果变得更糟.
科学领域:
- 新生儿免疫学 新生儿免疫学
- 炎症生物标志物 炎症生物标志物
- 早产婴儿的健康早产婴儿的健康
背景情况:
- 宫内生长限制 (IUGR) 与新生儿发病率的增加有关.
- 之前的研究表明,在IUGR产后婴儿中,促炎生物标志物升高.
- 在IUGR婴儿的纵向炎症概况需要进一步调查.
研究的目的:
- 评估早产婴儿与IUGR的纵向炎症概况.
- 为了比较IUGR和适合妊娠年龄 (AGA) 婴儿之间的炎症标志物和免疫细胞群.
- 了解从出生到新生儿重症监护室出院的炎症状态.
主要方法:
- 一项涉及24个IUGR和24个AGA早产婴儿 (≤32个6/7周妊娠年龄) 的病例控制研究.
- 血清样本使用多重检测分析了细胞因子 (IL-1β,sIL2Rα,IL-6,IL-8,IL-10,IP-10,MCP-1,MIP-1α,TNF-α).
- 通过流细胞测量分析的外周血液单核细胞,以评估免疫细胞种群.
主要成果:
- 在IUGR和AGA组之间出生体重和百分位数的显著差异.
- 在入院期间在IUGR婴儿中观察到升高的IL-8,IL-10和MCP-1.
- 在IUGR产后一个月的婴儿中增加了激活的经典单细胞和细胞毒性T细胞,尽管总体上没有人群差异.
结论:
- IUGR有助于持续的胎儿和新生儿前炎症状态,由升高的IL-8和MCP-1证明.
- 在IUGR婴儿中激活单细胞和细胞毒性T细胞的增加表明在组织特异性炎症中起作用.
- 这种促炎状态可能会加剧早产IUGR婴儿的新生儿后果.
更多相关视频
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
10.2K
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
3.7K
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...